Truist Securities maintains Buy rating on Zymeworks
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
05:31:44 PM UTC
SquawkNews
Zymeworks Is Maintained at Buy by Truist Securities
05:32:00 PM UTC
SquawkNews
Zymeworks Price Target Raised to $34.00/Share From $32.00 by Truist Securities